MHC class I recognition by monocyte-/macrophage-specific receptors

Area of Science:

• Immunology
• Transplantation Biology
• Cellular and Molecular Medicine

Background:

• Major Histocompatibility Complex (MHC) antigens dictate self/non-self discrimination in transplantation.
• T lymphocytes were historically considered the sole effector cells in allograft rejection.
• Athymic nude rodents' inability to reject allografts supported the T cell-centric view.

Purpose of the Study:

• To investigate the role of non-T cells, specifically macrophages, in allograft rejection.
• To identify and characterize monocyte/macrophage MHC receptors (MMRs).
• To elucidate the combined roles of MMRs and T-cell receptors in transplant rejection.

Main Methods:

• Transplantation of tumor cells and skin allografts in mice.
• Utilizing CD4 or CD8 knockout mouse models.
• Isolation of cDNA clones for monocyte/macrophage MHC receptors (MMRs).
• Generation of MHC-transgenic mice and lymphoma cells.
• Assessment of allograft rejection in MMR-deficient mice.

Main Results:

• Macrophages demonstrated cytotoxicity against allografts.
• Evidence indicated non-T cells as effector cells in skin and organ allograft rejection.
• MMRs for specific MHC alleles (H-2D(d), H-2K(d)) were identified.
• MMR-deficient mice showed impaired rejection of transgenic skin allografts.
• T-cell receptor was essential for lymphoma rejection.

Conclusions:

• Macrophages play a significant role as effector cells in allograft rejection, challenging the T cell-exclusive paradigm.
• Monocyte/macrophage MHC receptors (MMRs) are critical for recognizing and mediating rejection of foreign MHC antigens.
• Both MMRs and T-cell receptors are essential, highlighting a complex interplay in transplant rejection mechanisms.